Koster, Andreas <br/><br/>
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.  [electronic resource] 

 -  The Annals of thoracic surgery  Feb 2007 
 - 572-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-6259 
<br/><br/><label>Standard No.: </label>10.1016/j.athoracsur.2006.09.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Aged, 80 and over<br/>Antibodies--blood<br/>Anticoagulants--adverse effects<br/>Blood Loss, Surgical<br/>Cardiopulmonary Bypass<br/>Erythrocyte Transfusion--statistics & numerical data<br/>Female<br/>Heparin--adverse effects<br/>Hirudins<br/>Humans<br/>Intraoperative Care<br/>Male<br/>Middle Aged<br/>Peptide Fragments--therapeutic use<br/>Recombinant Proteins--therapeutic use<br/>Syndrome<br/>Thrombocytopenia--chemically induced<br/>Thrombosis--chemically induced<br/>Time Factors<br/>Treatment Outcome